Ectopic Pregnancy Clinical Trials

Find Ectopic Pregnancy Clinical Trials Near You

Doppler Flow in Tubal Ectopic Pregnancy in Diagnosis as a Predictor of Treatment Success - Conservative and MTX Treatment

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

The study Doppler Flow in Tubal Ectopic Pregnancy as a Predictor of Treatment Success: Conservative and MTX Therapy aims to evaluate the role of Doppler ultrasound parameters (RI, PI, and PSV) in predicting treatment success for tubal ectopic pregnancies. Ectopic pregnancies, affecting \ 2% of all pregnancies (98% in fallopian tubes), pose significant risks, including rupture and maternal mortality. Diagnosis is typically achieved via transvaginal ultrasound, with Doppler imaging enhancing accuracy by detecting characteristic vascular patterns. Management options include conservative monitoring, methotrexate (MTX) therapy, or surgery, based on clinical stability, β-hCG levels, and ultrasound findings. While β-hCG levels are a known predictor of MTX treatment failure, there is no consensus on an optimal threshold. Prior research suggests increased vascularization on Doppler ultrasound may correlate with higher MTX success rates. This prospective study will involve 60 women aged 18-45 with stable, unruptured tubal ectopic pregnancies. It will assess Doppler parameters and other clinical factors as predictors of treatment success. Findings aim to address gaps in the literature and improve management strategies for tubal ectopic pregnancies.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Maximum Age: 45
Healthy Volunteers: f
View:

• Tubal ectopic pregnancy

• Hemodynamically stable, with no suspicion of rupture,

• Eligible for MTX or conservative therapy.

Locations
Other Locations
Israel
Meir Medical Center
RECRUITING
Kfar Saba
Contact Information
Primary
Chen Manor Bar, MD
manor.chen@gmail.com
+972544414211
Backup
yael Yagur, MD
yael.yagur@clalit.org.il
+972523309429
Time Frame
Start Date: 2024-06-01
Estimated Completion Date: 2027-06-01
Participants
Target number of participants: 60
Treatments
Women diagnosed with tubal ectopic pregnancy who is a candidate for MTX or conservative therapy
Related Therapeutic Areas
Sponsors
Leads: Meir Medical Center

This content was sourced from clinicaltrials.gov